Anti-CD123-CART Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD123-CART Cells, covering 2017-06-14 to 2017-06-14. Get the full timeline:
Most recent: Clinical Trial Update: Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT [Phase 1]